Virlyn Bishop, MD
Anesthesiology · Atlanta, GANPI 1255516183
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,539 of the $4,953 with a category attached, or 71.4%. 28 manufacturers reported payments, led by Vertiflex, Inc. at 37.4% of the total. Reporting peaked in 2019 at $2,629 and has fallen 98.2% since, to $47 in 2025. Among anesthesiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $34.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$2K
- Nevro Corp.$620
- Scilex Pharmaceuticals Inc.$522
- Boston Scientific$468
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$260
- Medtronic$250
- plus $979 from 22 others
What the payments were for
- Travel & lodging$1,41429%
- Food & beverage$3,53971%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 14 | $1,854 |
| Nevro Corp. | 14 | $620 |
| Scilex Pharmaceuticals Inc. | 25 | $522 |
| Boston Scientific | 19 | $468 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $260 |
| Medtronic(2 entities) | 3 | $250 |
| Abbott | 3 | $155 |
| Collegium Pharmaceutical, Inc. | 8 | $122 |
| Vertos Medical, Inc. | 2 | $79 |
| Amgen | 4 | $75 |
| Assertio Therapeutics, Inc. | 4 | $69 |
| Pfizer | 5 | $60 |
| Painteq LLC | 3 | $49 |
| Azurity Pharmaceuticals, Inc. | 3 | $46 |
| Biodelivery Sciences International, Inc. | 3 | $40 |
| Forte Bio-pharma LLC | 2 | $37 |
| Nalu Medical, Inc. | 1 | $32 |
| Merck | 1 | $28 |
| Almatica Pharma LLC | 2 | $26 |
| Virtus Pharmaceuticals LLC | 2 | $24 |
| Relievant Medsystems, Inc. | 1 | $24 |
| Atland Pharmaceuticals, LLC | 1 | $23 |
| Chiesi USA, Inc. | 1 | $22 |
| AbbVie | 1 | $20 |
| AstraZeneca | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
| Galt Pharmaceuticals, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,452
- Omnia$237
- Senza Spinal Cord Stimulation System$148
- INTELLIS ADAPTIVESTIM$136
- PROCLAIM$119
- RESTORE$104
- GENERAL PAIN MANAGEMENT$100
How this compares
$4,953 in reported general payments places this provider in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 19 | $16,545 |
| MovantikNaloxegol Oxalate | 13 | $5,320 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 124 | $4,307 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 84 | $1,806 |
| Fentanyl | 14 | $1,723 |
| Gabapentin | 101 | $1,409 |
| Pregabalin | 48 | $1,180 |
| Oxycodone Hcl | 55 | $1,166 |
| Tramadol Hcl | 80 | $532 |
| Cyclobenzaprine Hcl | 34 | $441 |
| Tizanidine Hcl | 51 | $425 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $293 |
| Methocarbamol | 18 | $200 |
| Baclofen | 19 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $122 | $16,54519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Other anesthesiology in Atlanta
- Mark HamiltonAtlanta$351K
- Michael AshmoreAtlanta$214K
- Uma ShastriAtlanta$35K
- Melat GebreAtlanta$16K
- Laura DowneyAtlanta$15K
- Peter SebelAtlanta$14K
- Simon LeeAtlanta$12K
- Julia EidelmanAtlanta$10K
- Kathryn GlasAtlanta$10K
- Roman SnieckinskiAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.